Skip to main content
SpringerLink
Log in

Prenatal test for Down syndrome not cost effective in Spain

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2015 euros

Reference

  • Bayon JC, et al. The consequences of implementing non-invasive prenatal testing with cell-free foetal DNA for the detection of Down syndrome in the Spanish National Health Service: a cost-effectiveness analysis. Cost Effectiveness and Resource Allocation : 1 Mar 2019. Available from: URL: https://doi.org/10.1186/s12962-019-0173-8

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Prenatal test for Down syndrome not cost effective in Spain. PharmacoEcon Outcomes News 823, 26 (2019). https://doi.org/10.1007/s40274-019-5716-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-019-5716-x

Search

Navigation